Challenges and developments in both surgical and non-surgical treatments for thyroid eye disease

References

• Dolman PJ. Evaluating graves orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26:229–248.
   PubMed Web of Science ®Google Scholar
• Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362:726–738.
   PubMed Web of Science ®Google Scholar
• Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves’ ophthalmopathy on quality of life. J Endocrinol Invest. 2004;27:259–264. Review.
   PubMed Web of Science ®Google Scholar
• Fayers T, Dolman PJ. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease. Br J Ophthalmol. 2011;95:1670–1674.
   PubMed Web of Science ®Google Scholar
• Rundle FF. Development and course of exophthalmos and ophthalmoplegia in Graves’ disease with special reference to the effect of thyroidectomy. Clin Sci. 1945;5:177–194.
   PubMed Web of Science ®Google Scholar
• Mourits MP, Prummel MF, Wiersinga WM, et al. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol. 1997;47:9.
   PubMed Web of Science ®Google Scholar
• Dolman PJ, Rootman J. VISA classification for graves orbitopathy. Ophthal Plast Reconstr Surg. 2006;22:319–24.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. European J Endocrinol. 2008;158:273–285.
   PubMed Web of Science ®Google Scholar
• Kahaly GJ, Pitz S, Hommel G, et al. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves’ orbitopathy. J Clin Endocrinol Metab. 2005;90:5234–5240.
   PubMed Web of Science ®Google Scholar
• Kendall-Taylor P, Crombie AL, Stephenson AM, et al. Intravenous methylprednisolone in the treatment of Graves’ ophthalmopathy. BMJ. 1988;297:1574–1578.
   PubMedGoogle Scholar
• Shams PN, Ma R, Pickles T, et al. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease. Am J Ophthalmol. 2014;157:1299–1305.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Krassas GE, Wiersinga W, et al. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves’ orbitopathy. J Clin Endocrinol Metab. 2012;97:4454–4456.
   PubMed Web of Science ®Google Scholar
• Dolman PJ, Rath S. Orbital radiotherapy for thyroid eye disease. Curr Opin Ophthalmol. 2012;23:427–432.
   PubMed Web of Science ®Google Scholar
• Prummel MF, Terwee CB, Gerding MN, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab. 2004;89:15–20.
   PubMed Web of Science ®Google Scholar
• Mourits MP, van Kempen-Harteveld ML, Garcia MB, et al. Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study. Lancet. 2000;355:1505–1509.
   PubMed Web of Science ®Google Scholar
• Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves’ ophthalmopathy. Ophthalmology. 2001;108:1523–1534.
   PubMed Web of Science ®Google Scholar
• Rajendram R, Taylor PN, Wilson VJ, et al. Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre 2X 2 factorial, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2018;6(4):299–309.
   PubMed Web of Science ®Google Scholar
• Stan MN, Garrity JA, Carranza Leon BG, et al. Randomized controlled trial of rituximab in patients with Graves’ orbitopathy. J Clin Endocrinol Metab. 2015;100:432–441.
   PubMed Web of Science ®Google Scholar
• Hegedus L, Smith TJ, Douglas RS, et al. Targeted biological therapies for Graves’ disease and thyroid associated ophthalmopathy focus on B cell depletion with Rituximab. Clin Endocrinol (Oxf). 2011;74: 1–8.
   PubMed Web of Science ®Google Scholar
• Salvi M, Vannucchi G, Curro N, et al. Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves’ orbitopathy: a randomized controlled study. J Clin Endocrinol Metab. 2015;100:422–431.
   PubMed Web of Science ®Google Scholar
• Marcocci C, Kahaly GJ, Krassas GE, et al. Selenium and the course of mild Graves’ orbitopathy. N Engl J Med. 2011;364:1920–1931.
   PubMed Web of Science ®Google Scholar
• Perez-Moreiras JV, Alvarez-Lopez A, Gomez EC. Treatment of active corticosteroid-resistant Graves’ orbitopathy. Ophthal Plast Reconstr Surg. 2014;30:162–167.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Kahaly GJ, Ezra DG, et al. Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med. 2017;376:1748–1761.
   PubMed Web of Science ®Google Scholar
• Costa PG, Saraiva FP, Pereira IC, et al. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye (Lond). 2009;23:767–773,
   PubMed Web of Science ®Google Scholar
• Xu D, Liu Y, Xu H, et al. Repeated triamcinolone acetonide injection in the treatment of upper lid retraction in patients with thyroid associated ophthalmopathy. Can J Ophthalmol. 2012;47:34.
   PubMed Web of Science ®Google Scholar
• Grisolia ABD, Couso RC, Matayoshi S, et al. Non-surgical treatment for eyelid retraction in thyroid eye disease (TED). Br J Ophthalmol. 2018;102:158-163.
   Web of Science ®Google Scholar
• Mancini R, Khadavi NM, Goldberg RA. Non-surgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler. Ophthal Plast Reconstr Surg. 2011;27:1–3.
   PubMed Web of Science ®Google Scholar
• Rabinowitz MP, Katz LJ, Moster MR, et al. Unilateral prostaglandin-associated periorbitopathy: a syndrome involving upper eyelid retraction distinguishable from the aging sunken eyelid. Ophthal Plast Reconstr Surg. 2015;31:373–378.
   PubMed Web of Science ®Google Scholar
• Rootman DB, Golan S, Pavlovich P, et al. Postoperative changes in strabismus, ductions, exophthalmometry, and eyelid retraction after orbital decompression for thyroid orbitopathy. Ophthal Plast Reconstr Surg. 2017;33:289–293.
   PubMed Web of Science ®Google Scholar
• Kim DB, Meyer DR, Simon JW. Retractor lysis as prophylaxis for lower lid retraction following inferior rectus recession. J Pediatr Ophthalmol Strabismus. 2002;39:198–202.
   PubMed Web of Science ®Google Scholar
• Park HH, Chun YS, Moon NJ, et al. Change in eyelid parameters after orbital decompression in thyroid-associated orbitopathy. Eye. 2018. Epub.
   Google Scholar
• Davies MJ, Dolman PJ. Levator muscle enlargement in thyroid eye disease-related upper eyelid retraction. Ophthal Plast Reconstr Surg. 2017;33:35–39.
   PubMed Web of Science ®Google Scholar
• Fayers T, Barker LE, Verity DH, et al. Oscillopsia after lateral wall orbital decompression. Ophthalmology. 2013;120:1920–1923.
   PubMed Web of Science ®Google Scholar
• Richter DF, Stoff A, Olivari N. Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (olivari technique): experience and progression after more than 3000 operations over 20 years. Plast Reconstr Surg. 2007;120:109–123.
   PubMed Web of Science ®Google Scholar
• Prat MC, Braunstein AL, Glass LRD, et al. Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection. Ophthal Plast Reconstr Surg. 2015;31:215–218.
   PubMed Web of Science ®Google Scholar
• Rootman DB. Orbital decompression for thyroid eye disease. Surv Ophthalmol. 2018;63(1):86–104.
   PubMed Web of Science ®Google Scholar
• Wray RC, Holtmann B, Ribaudo JM, et al. A comparison of conjunctival and subciliary incisions for orbital fractures. Brit J Plast Surg. 1977;30:142–145.
   PubMedGoogle Scholar
• Ridgway EB, Chen C, Colakoglu S, et al. The incidence of lower eyelid malposition after facial fracture repair: a retrospective study and meta-analysis comparing subtarsal, subciliary, and transconjunctival incisions. Plast Reconstr Surg. 2009;124:1578–1586.
   PubMed Web of Science ®Google Scholar
• Goldberg RA, Shorr N, Cohen MS. The medial orbital strut in the prevention of postdecompressive dystopia in dysthyroid ophthalmopathy. Ophthal Plast Reconstr Surg. 1992;8:32–34.
   PubMed Web of Science ®Google Scholar
• Mourits MP, Koornneef L, Wiersinga WM, et al. Orbital decompression for Graves’ ophthalmopathy by inferomedial, byinferomedial plus lateral, and by coronal approach. Ophthalmology. 1990;97:636–641.
   PubMed Web of Science ®Google Scholar
• Matic DB and Kim S. Temporal Hollowing following Coronal Incision: A Prospective, Randomized, Controlled Trial. Plast Reconstruct Surg. 2008;121(6):379–385.
   Google Scholar
• Baldeschi L. Small versus coronal incision orbital decompression in Graves’ orbitopathy. Orbit. 2010;29:177–182.
   PubMedGoogle Scholar
• Maier W, Laszig R. Complications of endonasal paranasal sinus surgery, diagnostic and therapeutic consequences. Laryngorhinootologie. 1998;7:402–409.
   Web of Science ®Google Scholar
• Maalouf T, Vedrine PO, Coffinet L, et al. Mid-term rhinosinusal consequences of bony orbital decompression in Graves’ disease: a retrospective study. Orbit. 2008;27:169–173.
   PubMedGoogle Scholar
• Ogura JH, Walsh TE. The transantral orbital decompression operation for progressive exophthalmos. Laryngoscope. 1962;72:1078–1097.
   PubMedGoogle Scholar
• Reich SS, Null RC, Timoney PJ, et al. Trends in orbital decompression techniques of surveyed American Society of Ophthalmic Plastic and Reconstructive Surgery Members. Ophthal Plast Reconstr Surg. 2016;32:434–437.
   PubMed Web of Science ®Google Scholar
• Carrasco JR, Castillo I, Bilyk JR, et al. Incidence of infraorbital hypesthesia and sinusitis after orbital decompression for thyroid-related orbitopathy: a comparison of surgical techniques. Ophthal Plast Reconstr Surg. 2005;3:188–191.
   Web of Science ®Google Scholar
• DeFreitas J, Lucente FE. The caldwell-luc procedure: institutional review of 670 cases: 1975–1985. Laryngoscope. 1988;98:1297–1300.
   PubMed Web of Science ®Google Scholar
• Kennedy DW, Goodstein ML, Miller NR, et al. Endoscopic transnasal orbital decompression. Arch Otolaryng Head Neck Surg. 1990;116:275–282.
   PubMedGoogle Scholar
• Kennedy DW. Functional endoscopic sinus surgery. Tech Arch Otolaryngol. 1985;111:643–649.
   PubMed Web of Science ®Google Scholar
• Seiff SR, Shorr N. Nasolacrimal drainage system obstruction after orbital decompression. Am J Ophthalmol. 1988;106:204–209.
   PubMed Web of Science ®Google Scholar
• Dutton JJ. Orbital complications of paranasal sinus surgery. Ophthal Plast Reconstr Surg. 1986;2:119–127.
   PubMedGoogle Scholar
• Dubin MR, Tabaee A, Scruggs JT, et al. Image-guided endoscopic orbital decompression for Graves’ orbitopathy. Ann Otol Rhinol Laryngol. 2008;117:177–185.
   PubMed Web of Science ®Google Scholar
• Maniglia AJ, Chandler JR, Goodwin WJ, et al. Rare complications following ethmoidectomies: a report of eleven cases. Laryngoscope 1981;91:1234–1244.
   PubMed Web of Science ®Google Scholar
• Isenberg SF, Scott JA. Management of massive hemorrhage during endoscopic sinus surgery. Otol Head Neck Surg. 1994;111:134–136.
   PubMed Web of Science ®Google Scholar
• Mahoney N, Grant MP, Susarla SM, et al. Computer-assisted three-dimensional planning for orbital decompression craniomaxillofac. Trauma Reconstr. 2015;8:211–217.
   Google Scholar
• Servat JJ, Elia MD, Gong D, et al. Electromagnetic image-guided orbital decompression: technique, principles, and preliminary experience with 6 consecutive cases. Orbit. 2014;33:433–436.
   PubMedGoogle Scholar
• Wu CY, Kahana A. Stereotactic navigation with a registration mask in orbital decompression surgery: preliminary results. Ophthal Plast Reconstr Surg. 2015;31:440–444.
   PubMed Web of Science ®Google Scholar
• Leong SC, Karkos PD, Macewen CJ, et al. A systematic review of outcomes following surgical decompression for dysthyroid orbitopathy. Laryngoscope. 2009;119:1106–1115.
   PubMed Web of Science ®Google Scholar
• Alper MG. Pioneers in the history of orbital decompression for Graves’ ophthalmopathy. Doc Ophthalmolog. 1995;89:163–171.
   PubMed Web of Science ®Google Scholar
• Stallard HB. Evolution of lateral orbitotomy. Trans Ophthalmol Soc UK. 1973;93:3–17.
   PubMedGoogle Scholar
• Berke RN. A modified kronlein operation. Trans Am Ophthalmol Soc. 1953;51:193–231.
   PubMedGoogle Scholar
• Stewart WB, Levin PS, Toth BA. Orbital surgery – the technique of coronal scalp flap approach to the lateral orbitotomy. Arch ophthalmol. 1988;106:1724–1726.
   PubMedGoogle Scholar
• Harris GJ, Logani SC. Eyelid crease incision for lateral orbitotomy. Ophthal Plast Reconstr Surg. 1999;15:9–16.
   PubMed Web of Science ®Google Scholar
• Paridaens D, Verhoeff K, Bouwens D, et al. Transconjunctival orbital decompression in Graves’ ophthalmopathy: lateral wall approach ab interno. Brit J Ophthalmol. 2000;84:775–781.
   PubMed Web of Science ®Google Scholar
• Kennerdell JS, Maroon JC. An orbital decompression for severe dysthyroid exophthalmos. Ophthalmology. 1982;89:467–472.
   PubMed Web of Science ®Google Scholar
• Mehta P, Durrani OM. Outcome of deep lateral wall rim-sparing orbital decompression in thyroid-associated orbitopathy: a new technique and results of a case series. Orbit. 2011;30:265–268.
   PubMedGoogle Scholar
• Goldberg RA, Kim AJ, Kerivan KM. The lacrimal keyhole, orbital door jamb, and basin of the inferior orbital fissure. Arch ophthalmol. 1998;1161618–1624.
   PubMedGoogle Scholar
• Wirtschafter JD, Chu AE. Lateral orbitotomy without removal of the lateral orbital rim. Arch Ophthalmol. 1988;106:1463–1468.
   PubMedGoogle Scholar
• Korinth MC, Ince A, Banghard W, et al. Follow-up of extended pterional orbital decompression in severe Graves’ ophthalmopathy. Actaneurochirurgica. 2002;144:113–120.
   Google Scholar
• Fichter N, Guthoff RF. Results after en bloc lateral wall decompression surgery with orbital fat resection in 111 patients with Graves’ orbitopathy. Int J Endocrinol 2015. Epub.
   PubMed Web of Science ®Google Scholar
• Ueland HO, Haugen OH, Rodahl E. Temporal hollowing and other adverse effects after lateral orbital wall decompression. Acta Ophthalmol. 2016;94(8):793–797.
   PubMed Web of Science ®Google Scholar
• Wu CY, Niziol LM, Musch DC, et al. Thyroid-related orbital decompression surgery: a multivariate analysis of risk factors and outcomes. Ophthal Reconstr Surg. 2017;33:189–195.
   PubMed Web of Science ®Google Scholar
• Borumandi F, Hamer B, Kamer L, et al. How predictable is exophthalmos reduction in grave’s orbitopathy? A review of the literature. Br J Ophthalmol. 2011;95:1625–1630.
   PubMed Web of Science ®Google Scholar
• Mainville NP, Jordan DR. Effect of orbital decompression on diplopia in thyroid-related orbitopathy. Ophthal Plast Reconstr Surg. 2014;30:137–140.
   PubMed Web of Science ®Google Scholar
• Peragallo JH, Velez FG, Demer JL, et al. Postoperative drift in patients with thyroid ophthalmopathy undergoing unilateral inferior rectus muscle recession. Strabismus. 2013;21:23–28.
   PubMedGoogle Scholar